Arlene Naranjo | Research | University of Florida

Skip to main content All experts

ASO PRG DIR & RES ASO PROF

PHHP-COM BIOSTATISTICS

Orcid identifier0000-0001-7737-4324 (opens in a new tab)⁠

ASO PRG DIR & RES ASO PROF
PHHP-COM BIOSTATISTICS

anaranjo@cog.ufl.edu (opens in a new tab)

sort by:

GRANT
Tumor and Host Immune signatures associated with health disparities in outcomes following GD2 immunotherapy in neuroblastoma
National Institute of Health Nci13 Jan 2025 - 30 Jun 2026
Expired
GRANT
Children's Oncology Group Statistics and Data Center
National Institute of Health Nci1 Mar 2023 - 28 Feb 2026
Expired
GRANT
Comprehensive Evaluation of Immune Function in Patients Receiving Multimodal Therapy for High-Risk Neuroblastoma
US Army Med Research Acquisition8 Dec 2022 - 31 Aug 2026
Active
GRANT
Novel Health Equity Intervention to Improve Pediatric Oncology Outcome Disparities: Targeting Poverty and Psychosocial Stress
National Institute of Health Nci1 Apr 2022 - 1 Sep 2023
Expired
GRANT
Statistical Support for COG Neuroblastoma Projects
Childrens Hospital Philadelphia1 Jan 2022 - 14 Sep 2024
Expired
GRANT
Robust assays to define telomere maintenance mechanisms as cancer biomarkers
National Institute of Health Nci27 Oct 2021 - 31 Aug 2026
Active
GRANT
Alternate telomere maintenance mechanisms in high-risk neuroblastoma as prognostic indicators and therapeutic targets
National Institute of Health Nci15 Jul 2021 - 31 Jul 2022
Expired
GRANT
Integration of Lorlatinib to improve outcomes for patients with high-risk ALK-driven neuroblastoma: A COG and SIOPEN/Gustave Roussy international collaboration
Solving Kids' Cancer15 Mar 2021 - 30 Nov 2024
Expired
GRANT
Characterizing tumor evolution and therapy resistance in high-risk neuroblastoma
US Army Med Research Acquisition5 Feb 2021 - 14 Sep 2024
Expired
GRANT
Statistical analysis for COG Neuroblastoma Committee projects
University of Chicago26 Aug 2020 - 31 Jul 2022
Expired
GRANT
Project A: Biomarkers to Guide Therapy Selection in Children with High-Risk Neuroblastoma
Childrens Hospital Philadelphia16 Apr 2020 - 14 Sep 2024
Expired
GRANT
Project B: Biomarkers to Guide Therapy Selection in Children with High-Risk Neuroblastoma
Childrens Hospital Philadelphia16 Apr 2020 - 14 Sep 2024
Expired
GRANT
Statistical Analysis for COG Neuroblastoma Committee Projects
Seattle Childrens Hospital19 Aug 2019 - 31 Jul 2024
Expired
GRANT
Molecular assays defining telomere lengthening mechanisms (TLM) as neuroblastoma prognostic markers for potential integration into a revised COG neuroblastoma risk classifier
National Institute of Health Nci25 Apr 2019 - 30 Jun 2021
Expired
GRANT
Children's Oncology Group Statistics and Data Center
National Institute of Health Nci1 Mar 2019 - 28 Feb 2023
Expired
GRANT
Tumor and host markers of clinical outcomes after MIBG therapy in neuroblastoma
National Institute of Health Nci25 Jan 2019 - 31 Mar 2022
Expired
GRANT
DISCOVERING MECHANISMS OF NEUROBLASTOMA TUMORIGENESIS TO IMPROVE PATIENT OUTCOMES
National Institute of Health Nci14 Aug 2018 - 31 Aug 2024
Expired
GRANT
Genomic and functional characterization of a panel of neuroblastoma patient-derived xenografts and cell lines
National Institute of Health Nci23 Jan 2018 - 30 Nov 2020
Expired
GRANT
Late Effects after High Risk Neuroblastoma - The Leahrn Study Y
St Baldricks Foundation31 Mar 2016 - 30 Jun 2021
Expired
GRANT
Molecular Diagnostics for Risk Stratification and Monitoring of Neuroblastoma
National Institute of Health Nci25 Sep 2015 - 28 Feb 2017
Expired
GRANT
The Genetic Basis of Neuroblastoma Tumorigenesis (GWAS)
National Institute of Health Nci27 May 2015 - 31 Mar 2018
Expired
GRANT
Isotretinoin Pharmacokinetics and Pharmacogenomics in High Risk Neuroblastoma
National Institute of Health22 Dec 2014 - 31 Jul 2017
Expired
GRANT
The Interactive International Neuroblastoma Risk Group Database
St Baldricks Foundation29 May 2014 - 30 Jun 2016
Expired

MsArlene Naranjo

GRANTS